Rare diseases
Investigational molecules
Locations
A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome
FranceA Study of Mevrometostat and Enzalutamide for Men with Metastatic Castration-Sensitive Prostate Cancer Who Have Not Received Hormonal Therapy or Chemotherapy
BelgiumA study testing ALN-4324 for safety and effectiveness in overweight to obese patients with type 2 diabetes
GermanyStudy of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab
BelgiumStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
DenmarkA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
DenmarkA Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis
FranceA Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency
SpainA Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness
FranceA study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer's disease dementia
ItalyA Study of CLDN6 CAR-T Cell Therapy With or Without CLDN6 RNA-LPX Vaccine in Patients With CLDN6-Positive Advanced Solid Tumors That Returned or Did Not Respond to Treatment
GermanyStudy of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
